Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan
ConclusionsThis is the first report to evaluate T-DXd-related ILD/pneumonitis cases in clinical practice. Our findings are consistent with previous reports and suggest that patients with DAD patterns have poor outcomes. Evaluation of a larger real-world dataset may further identify predictors of clinical outcome.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Corticosteroid Therapy | Herceptin | Interstitial Lung Disease | Japan Health | Pneumonia